COMP <GO>
EVH vs HD // DIVIDEND YIELD & FCF PAYOUT SAFETY
Evolent Health Inc (Class A) (NYSE) VS. Home Depot Inc. (NYSE) • 15-METRIC TALLY: EVH 1
— HD 10
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: HD
LAST: $4.45 (+3.49%) • MKT CAP: $486.2M
dividend-safety
0.00%
LAST: $341.15 (+3.63%) • MKT CAP: $328.44B
dividend-safety
2.79%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EVH VS. HD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EVH | HD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.30% | 33.30% | -12.00 | HD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -26.30% | 32.90% | -59.20 | HD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.08% | 2.72% | +5.36 | EVH | /fcf-yield <GO> |
| Operating Margin | -21.90% | 12.70% | -34.60 | HD | /operating-margins <GO> |
| Net Profit Margin | -30.90% | 8.60% | -39.50 | HD | /net-margins <GO> |
| Revenue Growth (YoY) | -26.60% | 3.20% | -29.80 | HD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 2.79% | -2.79 | HD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.64 | -5.44 | HD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | HD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.3 | 67.5 | -18.20 | HD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.88 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $486.2M | $328.44B | -$327.95B | HD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EVH REV | HD REV | EVH GROSS % | HD GROSS % | EVH FCF | HD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.88B | $164.68B | 21.3% | 33.3% | $38.8M | $8.91B |
| FY 2024 | $2.55B | $159.51B | 14.4% | 33.4% | $18.8M | $12.63B |
| FY 2023 | $1.96B | $152.67B | — | — | $142.6M | $14.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EVH // BETA —
HD // BETA 0.88